<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3606C3ED-A577-408B-B772-36C9080CDAF9"><gtr:id>3606C3ED-A577-408B-B772-36C9080CDAF9</gtr:id><gtr:name>Universite Montpellier</gtr:name><gtr:address><gtr:line1>Service Communication</gtr:line1><gtr:line2>5 bd Henri IV - BP 1017</gtr:line2><gtr:line3>34006 Montpellier Cedex 1</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9F2B1267-FBB2-44C9-9C77-00CC0005FEE8"><gtr:id>9F2B1267-FBB2-44C9-9C77-00CC0005FEE8</gtr:id><gtr:name>Kilimanjaro Christian Medical Centre (KCMS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C8C4D8F1-1BC1-4737-8CF3-E1A0EE24F5B4"><gtr:id>C8C4D8F1-1BC1-4737-8CF3-E1A0EE24F5B4</gtr:id><gtr:name>University of Ouagadougou</gtr:name><gtr:address><gtr:line1>09 BP 337 Ouagadougou 09</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/10FAF183-CB76-4C8A-8DEA-DEB911E34E1E"><gtr:id>10FAF183-CB76-4C8A-8DEA-DEB911E34E1E</gtr:id><gtr:name>International Center for Reproductive Health (ICRH)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Infectious and Tropical Diseases</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3606C3ED-A577-408B-B772-36C9080CDAF9"><gtr:id>3606C3ED-A577-408B-B772-36C9080CDAF9</gtr:id><gtr:name>Universite Montpellier</gtr:name><gtr:address><gtr:line1>Service Communication</gtr:line1><gtr:line2>5 bd Henri IV - BP 1017</gtr:line2><gtr:line3>34006 Montpellier Cedex 1</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9F2B1267-FBB2-44C9-9C77-00CC0005FEE8"><gtr:id>9F2B1267-FBB2-44C9-9C77-00CC0005FEE8</gtr:id><gtr:name>Kilimanjaro Christian Medical Centre (KCMS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C8C4D8F1-1BC1-4737-8CF3-E1A0EE24F5B4"><gtr:id>C8C4D8F1-1BC1-4737-8CF3-E1A0EE24F5B4</gtr:id><gtr:name>University of Ouagadougou</gtr:name><gtr:address><gtr:line1>09 BP 337 Ouagadougou 09</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/10FAF183-CB76-4C8A-8DEA-DEB911E34E1E"><gtr:id>10FAF183-CB76-4C8A-8DEA-DEB911E34E1E</gtr:id><gtr:name>International Center for Reproductive Health (ICRH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3F774323-0469-4DDF-82AD-CFFC512C6285"><gtr:id>3F774323-0469-4DDF-82AD-CFFC512C6285</gtr:id><gtr:firstName>Richard John</gtr:firstName><gtr:surname>Hayes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0BCF8282-6173-4B12-9AA2-B3E838EA96C8"><gtr:id>0BCF8282-6173-4B12-9AA2-B3E838EA96C8</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>Ross</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/45B7BC95-FCF0-4B46-9688-3BEB960FF150"><gtr:id>45B7BC95-FCF0-4B46-9688-3BEB960FF150</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Mabey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3CC9C285-F7E1-46F6-9DC4-AD451FFBE99B"><gtr:id>3CC9C285-F7E1-46F6-9DC4-AD451FFBE99B</gtr:id><gtr:firstName>Deborah</gtr:firstName><gtr:surname>Watson-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501954"><gtr:id>9AB166A1-A818-4242-815F-684104C76C72</gtr:id><gtr:title>Mwanza Intervention Trials Facility</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501954</gtr:grantReference><gtr:abstractText>We propose to establish a dedicated Intervention Trials Facility in Mwanza, Tanzania aimed at strengthening the capacity of Tanzania and the East African region to participate in HIV intervention trials. The Facility will be established by LSHTM working in close partnership with the Tanzanian National Institute for Medical Research (NIMR). It will provide a platform to meet local and regional needs, facilitate future research programmes funded by MRC, DFID, Wellcome Trust and other agencies, and help to leverage further capacity building support, for example from EDCTP.</gtr:abstractText><gtr:technicalSummary>We propose to establish a dedicated Intervention Trials Facility in Mwanza, Tanzania aimed at strengthening the capacity of Tanzania and the East African region to participate in HIV intervention trials. The Facility will be established by LSHTM working in close partnership with the Tanzanian National Institute for Medical Research (NIMR). It will provide a platform to meet local and regional needs, facilitate future research programmes funded by MRC, DFID, Wellcome Trust and other agencies, and help to leverage further capacity building support, for example from EDCTP.</gtr:technicalSummary><gtr:fund><gtr:end>2010-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2200001</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Center for Reproductive Health (ICRH)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>ICRH</gtr:description><gtr:id>F2C20877-861F-4186-A906-17BC44BF97F2</gtr:id><gtr:impact>Strengthening research capacity in Africa.</gtr:impact><gtr:outcomeId>dpN9eXe8xKS-1</gtr:outcomeId><gtr:partnerContribution>Coordinate an EDCTP-funded project: Characterisation of novel microbicide safety biomarkers in East and South Africa</gtr:partnerContribution><gtr:piContribution>Providing biostatistical expertise and training.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Microbicides Development Programme</gtr:department><gtr:description>Clinical trial: Microbicides Development Programme</gtr:description><gtr:id>124999AD-4E36-4389-867B-BE1A31383843</gtr:id><gtr:impact>Successful completion and publication of MDP301 Phase III trial; further publications in progress; capacity building in partner sites in Africa; development of proposal for MDP302 trial</gtr:impact><gtr:outcomeId>D02B4A6F14E-1</gtr:outcomeId><gtr:partnerContribution>Collaborative involvement in Phase III trial of Pro2000 vaginal microbicide</gtr:partnerContribution><gtr:piContribution>PI for Mwanza field site; statistical input to trial</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Medical Research, Tanzania</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:department>Mwanza Intervention Trials Unit (MITU)</gtr:department><gtr:description>NIMR Mwanza Centre</gtr:description><gtr:id>D536BE80-9A36-4F85-B4F0-41D4D6629252</gtr:id><gtr:impact>Strengthening research capacity in Africa; scientific publications; joint research grants</gtr:impact><gtr:outcomeId>mKjzV1hNisf-1</gtr:outcomeId><gtr:partnerContribution>Providing laboratory and logistical infrastructure and support.</gtr:partnerContribution><gtr:piContribution>Technical (epidemiological, statistical, clinical, research) and administrative support.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kilimanjaro Christian Medical Centre (KCMS)</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:description>Kilimanjaro Christian Medical Centre (KCMS)</gtr:description><gtr:id>35D9398E-8AD5-41F9-889A-B351497A2EAB</gtr:id><gtr:impact>Strengthening research capacity in Africa.</gtr:impact><gtr:outcomeId>51DA85E269B-1</gtr:outcomeId><gtr:partnerContribution>Research expertise: distribution of viral genotypes among high-risk and general populations; Role of co-morbidities in HIV pathogenesis and clinical course of HIV disease; Models of delivering care and treatment for people living with HIV/AIDS</gtr:partnerContribution><gtr:piContribution>Coordinated an EDCTP-funded project: Capacity development and strengthening in preparation for HIV vaccine trials in Tanzania and Burkina Faso</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ouagadougou</gtr:collaboratingOrganisation><gtr:country>Burkina Faso</gtr:country><gtr:description>University of Ouagadougou</gtr:description><gtr:id>67E7A41A-DA9D-4FBB-BDFB-06CF76976530</gtr:id><gtr:impact>Strengthening research capacity in Africa</gtr:impact><gtr:outcomeId>MNjesXbAupz-1</gtr:outcomeId><gtr:partnerContribution>Providing south-south capacity building and exchange of technical expertise with Africian collaborators</gtr:partnerContribution><gtr:piContribution>Coordinated an EDCTP-funded project: Capacity development and strengthening in preparation for HIV vaccine trials in Tanzania and Burkina Faso</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC/UVRI Uganda Research Unit on AIDS</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>MRC/UVRI Uganda Research Unit on AIDS</gtr:description><gtr:id>71E12844-BFB6-4E0B-A4CF-A0D1723B14CB</gtr:id><gtr:impact>Strengthening research capacity in East African region.</gtr:impact><gtr:outcomeId>66BBDF23B92-1</gtr:outcomeId><gtr:partnerContribution>Provided experience in Phase I/II clinical trials; colposcopy expertise; lab expertise; financial and administrative capacity building support.</gtr:partnerContribution><gtr:piContribution>Technical support (epidemiology and biostatistics)</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Center for Proverty-related Communicable Diseases</gtr:description><gtr:id>A255CE50-6264-4059-B1FF-017AD2B7D24B</gtr:id><gtr:impact>Strengthening research capacity in East African region.</gtr:impact><gtr:outcomeId>92992A2C718-1</gtr:outcomeId><gtr:partnerContribution>Monitoring of clinical trials; data management expertise; ethical and regulatory requirements advice</gtr:partnerContribution><gtr:piContribution>Technical support (epidemiology and biostatistics)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>MRC Clinical Trials Unit</gtr:description><gtr:id>3243C317-9DB5-45E8-BEAB-0D1E533E3EBA</gtr:id><gtr:impact>Strengthening research capacity in East African region.</gtr:impact><gtr:outcomeId>4FC1E3BA6B1-1</gtr:outcomeId><gtr:partnerContribution>Monitoring of clinical trials; data management expertise; ethical and regulatory requirements advice.</gtr:partnerContribution><gtr:piContribution>Technical support (epidemiology and biostatistics)</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Montpellier</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Laboratory of Bacteriology and Virology Montpellier</gtr:department><gtr:description>University of Montpellier</gtr:description><gtr:id>0A8E77E2-BECD-4D9F-90BD-C63751709804</gtr:id><gtr:impact>Strengthening research capacity in Africa</gtr:impact><gtr:outcomeId>GxQRxSvXSet-1</gtr:outcomeId><gtr:partnerContribution>Providing technical support in the area of laboratory capacity building and conducting proposed laboratory assays</gtr:partnerContribution><gtr:piContribution>Coordinated an EDCTP-funded project: Capacity development and strengthening in preparation for HIV vaccine trials in Tanzania and Burkina Faso</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Produced MITU biennial report</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>81329157-BFEF-4A01-BA1B-416EB9248901</gtr:id><gtr:impact>Produced the first MITU biennial report.

Distributed to researchers, research collaborations, funding organisations and the media.</gtr:impact><gtr:outcomeId>2340090CF25</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HSV-2 trial dissemination activities</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>B0F358E0-18B0-4483-B290-B0F175E0D6C2</gtr:id><gtr:impact>Dissemination of the results from the trial: &amp;quot;Clinical epidemiology of HSV-2 and the impact of HSV suppressive therapy to reduce HIV incidence in high risk women, Tanzania&amp;quot; through workshops, international conferences and meetings and publications in scientific journals.

Dissemination of the results from the trial: &amp;quot;Clinical epidemiology of HSV-2 and the impact of HSV suppressive therapy to reduce HIV incidence in high risk women, Tanzania&amp;quot; through workshops. Increased awareness about the association between HIV and HSV-2 in trial participants, scientists and health care workers in Tanzania.</gtr:impact><gtr:outcomeId>5FE94EC0F3D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MEMA Kwa Vijana Further Survey dissemination activities</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>8849526B-8062-4FE6-8C80-A9BDC0266416</gtr:id><gtr:impact>Dissemination of the results from the &amp;quot;MEMA Kwa Vijana Further Survey&amp;quot; (Adolescent Sexual and Reproductive Health intervention) through international and regional workshops.</gtr:impact><gtr:outcomeId>A6BDAB96A9C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific symposium: HIV Prevention - Where Now?</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>0DEDD950-2538-4404-AD5A-72A49EC6F2BD</gtr:id><gtr:impact>The symposium included keynote presentations reviewing the research evidence on major approaches to HIV prevention in adults and focused on the prevention of heterosexual transmission of HIV in Africa. There was discussion of research gaps, future directions and methodological approaches. The media were present.

An article on the symposium featured in &amp;quot;Tanzania AIDS Week in Review&amp;quot;.</gtr:impact><gtr:outcomeId>1B11D041D06</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop: MDP301 trial of Pro2000 microbicide gel</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>FBB03807-508B-4F47-A6AE-C0B8BC726ABC</gtr:id><gtr:impact>Subsantial proportion of women participating in trial attended dissemination workshops

NA</gtr:impact><gtr:outcomeId>aeyF8bjFRTp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>431687</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Delivery, uptake and acceptability of HPV vaccination in Tanzanian girls)</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3CD7B58C-F117-4045-A06C-ABFBF7E6836D</gtr:id><gtr:outcomeId>76B256BB29D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>EDCTP - Clinical trials/capacity building grants (Capacity development and strengthening in preparation for HIV vaccine trials in Tanzania and Burkina Faso)</gtr:description><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>243CE977-B384-4682-92DC-CFD85C9F85DB</gtr:id><gtr:outcomeId>091B68489970</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>84021</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IPM - Project Grant (Biomarkers for Microbicide Development)</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>International Partnership for Microbicides (IPM)</gtr:fundingOrg><gtr:id>F31FC6D9-2121-44E8-B640-72987FEAC91F</gtr:id><gtr:outcomeId>B4F31F2296A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>EDCTP - Clinical trials/capacity building grants (Site preparation and capacity strengthening for trials of vaginal microbicides in Tanzania and Uganda)</gtr:description><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>24A34F52-20AE-4527-BFED-90BA4C3CCD25</gtr:id><gtr:outcomeId>1CFDC5845F50</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>898104</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK - Clinicial trials</gtr:description><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>D530BA89-BCF7-47A3-A244-9B93ECA339B1</gtr:id><gtr:outcomeId>PAad6HAZtMs0</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1090982</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC research grant (Development of Mwanza Intervention Trials Unit as a centre of excellence in HIV/STI prevention research)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>66ADF4E5-EF51-48E7-8243-F8297B4704FC</gtr:id><gtr:outcomeId>kNsT9UL45Dr0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>604172</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (Intravaginal practices in Tanzania and Uganda: Relationships with the vaginal microenvironment and HIV)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>34563138-D6CA-4704-BAE6-746A5C10744E</gtr:id><gtr:outcomeId>47387F126530</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Findings of MDP301 trial</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6201B5F2-3B61-40C7-A2A2-AFABD853E44F</gtr:id><gtr:impact>Clear negative results of MDP301 trial of Pro2000 have provided firm basis to focus future microbicide research on antiretroviral-based microbicides</gtr:impact><gtr:outcomeId>Uu8dvWJnNK3</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HSV-2 trial results</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>D2C69647-403D-49C0-B262-699F221A6C75</gtr:id><gtr:impact>This was the first trial in the world to demonstrate that acyclovir had no effect on HIV incidence and the results have recently been published in the New England Journal of Medicine. The impact on policy being that this intervention would not now be seen as useful.</gtr:impact><gtr:outcomeId>EEA4FBDE03E</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MEMA Kwa Vijana Further Survey workshops attended by policymakers.</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>4316BE86-6BF2-455A-83E1-7B7BD0BE3187</gtr:id><gtr:impact>Impact on policymakers in Tanzania through their attendance at workshops.</gtr:impact><gtr:outcomeId>AB63D8EEE07</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Pictorial data collection tool in which participants record their vaginal practice and sexual history daily.</gtr:description><gtr:id>BC7A88DA-8BF7-46A4-BD61-308F44CF8A9C</gtr:id><gtr:impact>Submitted paper to Sexually Transmitted Diseases &amp;quot;Vaginal practices diary: development of a pictorial data collection tool for sensitive
behavioural data&amp;quot;</gtr:impact><gtr:outcomeId>FA8EEFF53E9</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Vaginal Practice Pictoral Diary</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A smear of the cell pellet of the cervicovaginal lavage specimen. The smear is prepared similarly to a blood film, fixed with methanol, stained and read by a technician proficient in doing manual differentials. The technician records the type and count of white blood cells present in the smear.</gtr:description><gtr:id>B65075B3-C2FC-49EE-B094-3B9ED660D888</gtr:id><gtr:impact>Currently undergoing evaluation.</gtr:impact><gtr:outcomeId>D508CE8D5B3</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Leukocyte Morphology Slide</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BB56DFCA-4FA7-46E6-A8A9-D65F79F82121</gtr:id><gtr:title>Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b78663db318ad79a3cf319b9bc1788c"><gtr:id>6b78663db318ad79a3cf319b9bc1788c</gtr:id><gtr:otherNames>Baisley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>5C86554521A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9225668D-218E-448C-9E79-299A01492405</gtr:id><gtr:title>Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>E418CD0AF17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3041D303-E40C-48ED-9E08-E629A934424E</gtr:id><gtr:title>Validity of coital diaries in a feasibility study for the Microbicides Development Programme trial among women at high risk of HIV/AIDS in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c101700f19571c90b93dcd262ed68e1a"><gtr:id>c101700f19571c90b93dcd262ed68e1a</gtr:id><gtr:otherNames>Allen CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>EE59718817E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83C2622A-439A-4065-8C6A-D94257364981</gtr:id><gtr:title>Aborting and suspending pregnancy in rural Tanzania: an ethnography of young people's beliefs and practices.</gtr:title><gtr:parentPublicationTitle>Studies in family planning</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d73343431b14a754b31436dc23cd851"><gtr:id>2d73343431b14a754b31436dc23cd851</gtr:id><gtr:otherNames>Plummer ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0039-3665</gtr:issn><gtr:outcomeId>A2B6759FD9A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E27694-5EAD-4978-9947-B72D959D07AF</gtr:id><gtr:title>Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>D899F3C01F5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43D13422-CD41-4904-8170-1A6AEC73154D</gtr:id><gtr:title>Modelling the cost-effectiveness of introducing rapid syphilis tests into an antenatal syphilis screening programme in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e23fa31165fb45166da484485b37293"><gtr:id>6e23fa31165fb45166da484485b37293</gtr:id><gtr:otherNames>Vickerman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>23AD73AB7E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0966ABF5-2346-43D5-A277-514E094D28D0</gtr:id><gtr:title>The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d37d831f7cc7077db21645b8ed08ed"><gtr:id>95d37d831f7cc7077db21645b8ed08ed</gtr:id><gtr:otherNames>Vallely A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>FF66AF0A537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C00EC9A-D136-48E9-B44D-8D3FBD91D7D6</gtr:id><gtr:title>Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5336c45429e06079cfa27cb14bdf976"><gtr:id>b5336c45429e06079cfa27cb14bdf976</gtr:id><gtr:otherNames>Doyle AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>577649BD_3577649BD_3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57236910-0F27-4FCD-8806-DD9E8B1305FB</gtr:id><gtr:title>A process evaluation of a school-based adolescent sexual health intervention in rural Tanzania: the MEMA kwa Vijana programme.</gtr:title><gtr:parentPublicationTitle>Health education research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d73343431b14a754b31436dc23cd851"><gtr:id>2d73343431b14a754b31436dc23cd851</gtr:id><gtr:otherNames>Plummer ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0268-1153</gtr:issn><gtr:outcomeId>E852023726A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC3EAAE-B4C6-4F05-8CA4-D54D1A4C0037</gtr:id><gtr:title>Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d37d831f7cc7077db21645b8ed08ed"><gtr:id>95d37d831f7cc7077db21645b8ed08ed</gtr:id><gtr:otherNames>Vallely A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>1BFEA391E66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07D7C357-0F87-470A-90C1-95304C3EB0CC</gtr:id><gtr:title>Circumcision among adolescent boys in rural northwestern Tanzania.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e71ad4d48ef9bef9e7d5fbe1bf10ff23"><gtr:id>e71ad4d48ef9bef9e7d5fbe1bf10ff23</gtr:id><gtr:otherNames>Weiss HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>9D31F9E6EAA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AFB5B77-DA34-49C3-9FEB-39EEDED6489D</gtr:id><gtr:title>Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania.</gtr:title><gtr:parentPublicationTitle>Contemporary clinical trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-7144</gtr:issn><gtr:outcomeId>1ACBA9FB700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE9A0726-6988-4535-AA95-1A9CFEA28E84</gtr:id><gtr:title>Rationale and design of the MEMA kwa Vijana adolescent sexual and reproductive health intervention in Mwanza Region, Tanzania.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1faf211da84e5350aadcf39baa088d73"><gtr:id>1faf211da84e5350aadcf39baa088d73</gtr:id><gtr:otherNames>Obasi AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn><gtr:outcomeId>B5D54F703AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64D37DBC-513A-48AE-8544-1E29C72DE9BC</gtr:id><gtr:title>Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41cb267e09762c4a4206ce102aaca910"><gtr:id>41cb267e09762c4a4206ce102aaca910</gtr:id><gtr:otherNames>Tanton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>8614BA5C_C8614BA5C_C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CC6D8D1-9897-49C5-84C3-01A9A77536BD</gtr:id><gtr:title>Farming with your hoe in a sack: condom attitudes, access, and use in rural Tanzania.</gtr:title><gtr:parentPublicationTitle>Studies in family planning</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d73343431b14a754b31436dc23cd851"><gtr:id>2d73343431b14a754b31436dc23cd851</gtr:id><gtr:otherNames>Plummer ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0039-3665</gtr:issn><gtr:outcomeId>64A980E46B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29389E04-6251-4F60-8E36-316B0254B5A7</gtr:id><gtr:title>From trial intervention to scale-up: costs of an adolescent sexual health program in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/364ab0bf33d0f2d36b2c959760be9d42"><gtr:id>364ab0bf33d0f2d36b2c959760be9d42</gtr:id><gtr:otherNames>Terris-Prestholt F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>F57FC528D89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07C972B3-6268-42A8-AE77-BAEE010719A4</gtr:id><gtr:title>A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/453f8722228f286af15e9492c58eee82"><gtr:id>453f8722228f286af15e9492c58eee82</gtr:id><gtr:otherNames>Shagi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn><gtr:outcomeId>DE6FC99FB9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F353D33B-2DE5-4357-A529-4B3D4666C336</gtr:id><gtr:title>How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>BMC medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d37d831f7cc7077db21645b8ed08ed"><gtr:id>95d37d831f7cc7077db21645b8ed08ed</gtr:id><gtr:otherNames>Vallely A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1472-6939</gtr:issn><gtr:outcomeId>F801D0E0_9F801D0E0_9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26B0A300-9955-4F9D-A766-8951CC308219</gtr:id><gtr:title>Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d32ae8ae3b66f93705d522ade5c3a28"><gtr:id>5d32ae8ae3b66f93705d522ade5c3a28</gtr:id><gtr:otherNames>Todd J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>25793414262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44FE0639-2437-47F7-A6E1-E8038629D9AD</gtr:id><gtr:title>Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>3ABEAC2471E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6330BFEA-0A2D-402F-A250-23B1F3319214</gtr:id><gtr:title>Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>99E7D2A72E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCB4D702-A507-4077-AE3D-642F6CCD90E6</gtr:id><gtr:title>Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/956b282636f8fe08438e0143dba8bf95"><gtr:id>956b282636f8fe08438e0143dba8bf95</gtr:id><gtr:otherNames>Everett DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>AE8CC9F7F02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF4CBDD5-B24C-45D1-9E9A-4911529D979A</gtr:id><gtr:title>Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfe468c29720504dc9f5c556649bd597"><gtr:id>dfe468c29720504dc9f5c556649bd597</gtr:id><gtr:otherNames>Orroth KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>E28BA020E57</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D701B58-15D5-4D4E-84A3-1308B08743DD</gtr:id><gtr:title>Low specificity of the Murex fourth-generation HIV enzyme immunoassay in Tanzanian adolescents.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/956b282636f8fe08438e0143dba8bf95"><gtr:id>956b282636f8fe08438e0143dba8bf95</gtr:id><gtr:otherNames>Everett DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>30E86D00BD3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B62CB04A-397D-431C-96F9-0F40FD31625F</gtr:id><gtr:title>Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilis.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a45070bd7a7de3c2de2a39132f9c21f"><gtr:id>5a45070bd7a7de3c2de2a39132f9c21f</gtr:id><gtr:otherNames>Mabey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>D8CACDE68C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1020E2B7-340F-4B5A-9BB3-CFBA69C42F0F</gtr:id><gtr:title>Comparison of sexual behavior data collected using a coital diary and a clinic-based interview during a microbicide pilot study in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab512941caeb1aae2accf5cc6383f6ac"><gtr:id>ab512941caeb1aae2accf5cc6383f6ac</gtr:id><gtr:otherNames>Lees S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>7318739C_27318739C_2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8EF1B1D-9124-4F3A-8A60-0302BE836AB6</gtr:id><gtr:title>Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>BMC medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d37d831f7cc7077db21645b8ed08ed"><gtr:id>95d37d831f7cc7077db21645b8ed08ed</gtr:id><gtr:otherNames>Vallely A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1472-6939</gtr:issn><gtr:outcomeId>63350E3D93B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C0F8F98-AF63-4739-AFC7-A7BD3C3D9D3A</gtr:id><gtr:title>PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba7304cedf2514ac5d61b9eba0e13eb7"><gtr:id>ba7304cedf2514ac5d61b9eba0e13eb7</gtr:id><gtr:otherNames>McCormack S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>e9xLcQ8fdqe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>750C2B7B-D7C2-40F9-BA7A-E5750F32299B</gtr:id><gtr:title>Are schools a good setting for adolescent sexual health promotion in rural Africa? A qualitative assessment from Tanzania.</gtr:title><gtr:parentPublicationTitle>Health education research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d73343431b14a754b31436dc23cd851"><gtr:id>2d73343431b14a754b31436dc23cd851</gtr:id><gtr:otherNames>Plummer ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0268-1153</gtr:issn><gtr:outcomeId>D9474AF4540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB12CF27-3C19-4B8C-8D4A-5E222F03ADD8</gtr:id><gtr:title>A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d73343431b14a754b31436dc23cd851"><gtr:id>2d73343431b14a754b31436dc23cd851</gtr:id><gtr:otherNames>Plummer ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn><gtr:outcomeId>73E7B18B_E73E7B18B_E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7292F736-C9BE-417D-843A-73B12FBBCC13</gtr:id><gtr:title>'The man who believed he had AIDS was cured': AIDS and sexually-transmitted infection treatment-seeking behaviour in rural Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d73343431b14a754b31436dc23cd851"><gtr:id>2d73343431b14a754b31436dc23cd851</gtr:id><gtr:otherNames>Plummer ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn><gtr:outcomeId>5694B22B07E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4639E203-B75A-49F3-B465-62C9CECAA18F</gtr:id><gtr:title>Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b83685714df7a9da58afb85fe799bcd9"><gtr:id>b83685714df7a9da58afb85fe799bcd9</gtr:id><gtr:otherNames>Ross DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>C8B43700995</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501954</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5841ECCD-C9B1-4B8B-993F-ACC8E9585125</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>3.1  Primary preventions interventions to modify behaviours or promote well-being</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>